NBP607 clinical trials
Also written NBP607.
How each study uses NBP607 is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
Studies by the year they started
7 studies that test it; most in 2013 (2)
| Year | Studies |
|---|---|
| 2012 | 1 |
| 2013 | 2 |
| 2014 | 2 |
| 2016 | 1 |
| 2018 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 7 · Other 0
Studies
Open first, then newest update. How each study uses NBP607 is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 7
- Immunogenicity and Safety of NBP607-QIV Compared to Agrippal in Children Aged 6 to 35 MonthsCompletedPhase 3SK Bioscience Co., Ltd.NCT03704740Written as NBP607-QIVHow we know
- Immunogenicity and Safety of Quadrivalent Influenza Vaccine (NBP607-QIV) in Adults and Elderly SubjectsCompletedPhase 3SK Chemicals Co., Ltd.NCT02467842Written as NBP607-QIVHow we know
- Safety, Tolerability and Immunogenicity of an Trivalent Inactivated Cell-Culture Influenza Vaccine in Healthy AdultsCompletedPhase 1SK Chemicals Co., Ltd.NCT03893669Written as NBP607How we know
- Immunogenicity and Safety of Quadrivalent Influenza Vaccine in Children Aged 6~35 MonthsCompletedPhase 3SK Chemicals Co., Ltd.NCT03020628Written as NBP607-QIVHow we know
- Immunogenicity and Safety of Quadrivalent Influenza Vaccine in Children and AdolescentsCompletedPhase 3SK Chemicals Co., Ltd.NCT02621164Written as NBP607-QIVHow we know
- Study of Egg-derived Influenza Vaccine and Cell Culture-derived Influenza Vaccine in Healthy Children and AdolescentsCompletedPhase 3SK Chemicals Co., Ltd.NCT02621177Written as NBP607How we know
- Study of Egg-derived Influenza Vaccine and Cell Culture-derived Influenza Vaccine in Adult and Elderly SubjectsCompletedPhase 3SK Chemicals Co., Ltd.NCT02344134Written as NBP607How we know